Edap Tms (NASDAQ:EDAP) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Edap Tms (NASDAQ:EDAP) in a report issued on Friday morning. The firm issued a hold rating on the medical equipment provider’s stock.

Edap Tms Stock Performance

Edap Tms stock opened at $2.15 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a 12 month low of $1.96 and a 12 month high of $8.50. The company has a fifty day moving average price of $2.42 and a two-hundred day moving average price of $2.51. The company has a market cap of $79.77 million, a PE ratio of -3.31 and a beta of 0.37.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The company had revenue of $22.69 million for the quarter, compared to the consensus estimate of $20.83 million. Research analysts expect that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Trading of Edap Tms

A number of institutional investors and hedge funds have recently made changes to their positions in EDAP. Parkman Healthcare Partners LLC bought a new stake in Edap Tms in the 3rd quarter valued at about $395,000. Jane Street Group LLC boosted its position in shares of Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 73,361 shares during the period. Schonfeld Strategic Advisors LLC grew its holdings in Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after buying an additional 52,500 shares in the last quarter. Millennium Management LLC increased its position in Edap Tms by 218.5% in the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares during the period. Finally, BNP Paribas Financial Markets grew its stake in shares of Edap Tms by 111.5% in the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 25,650 shares in the last quarter. 62.74% of the stock is currently owned by institutional investors and hedge funds.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.